Clinicopathological data of studied subjects
| Colorectal carcinoma patients (n = 58) | |
| Sex | |
| Male | 39 (68%) |
| Female | 19 (32%) |
| Age | |
| Range | 30–88 years old |
| Median | 67.5 years old |
| TNMa classification | |
| Tumor stage | |
| T1 | 0 (0%) |
| T2 | 15 (26%) |
| T3 | 30 (52%) |
| T4 | 13 (22%) |
| Lymph node status | |
| N0 | 21 (37%) |
| N1 | 24 (41%) |
| N2 | 13 (22%) |
| Degree in differentiation | |
| Well | 0 (0%) |
| Moderate | 44 (76%) |
| Poor | 14 (24%) |
| Colorectal adenoma patients (n = 49) | |
| Sex | |
| Male | 31 (63%) |
| Female | 18 (37%) |
| Age | |
| Range | 28–73 years old |
| Median | 53 years old |
| Degree in dysplasia | |
| Mild | 4 (8%) |
| Moderate | 31 (63%) |
| Severe | 14 (29%) |
| Apparently normal subjects (n = 43) | |
| Sex | |
| Male | 15 (34%) |
| Female | 28 (66%) |
| Age | |
| Range | 25–70 years old |
| Median | 34.5 years old |
| Colorectal carcinoma patients (n = 58) | |
| Sex | |
| Male | 39 (68%) |
| Female | 19 (32%) |
| Age | |
| Range | 30–88 years old |
| Median | 67.5 years old |
| TNMa classification | |
| Tumor stage | |
| T1 | 0 (0%) |
| T2 | 15 (26%) |
| T3 | 30 (52%) |
| T4 | 13 (22%) |
| Lymph node status | |
| N0 | 21 (37%) |
| N1 | 24 (41%) |
| N2 | 13 (22%) |
| Degree in differentiation | |
| Well | 0 (0%) |
| Moderate | 44 (76%) |
| Poor | 14 (24%) |
| Colorectal adenoma patients (n = 49) | |
| Sex | |
| Male | 31 (63%) |
| Female | 18 (37%) |
| Age | |
| Range | 28–73 years old |
| Median | 53 years old |
| Degree in dysplasia | |
| Mild | 4 (8%) |
| Moderate | 31 (63%) |
| Severe | 14 (29%) |
| Apparently normal subjects (n = 43) | |
| Sex | |
| Male | 15 (34%) |
| Female | 28 (66%) |
| Age | |
| Range | 25–70 years old |
| Median | 34.5 years old |
TNM, Tumor-Node-Metastasis.